Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Pacira Pharmaceuticals, Inc.
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.
Find out what a historical investment in Pacira Pharmaceuticals, Inc. would be worth today using our PCRX stock calculator.
Market Capitalisation
$890.84M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
449.83K
High today
$23.94
Low today
$22.62
Open price
$23.64
52-week high
$27.64
52-week low
$18.80
Ready to start your investing journey with Stake?
Open an accountHow do I buy PCRX shares in Australia?
Buying PCRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Pacira Pharmaceuticals, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PCRX
What is the ticker symbol of Pacira Pharmaceuticals, Inc.?
The ticker symbol for Pacira Pharmaceuticals, Inc. is PCRX.
How much is one share of PCRX?
One share of PCRX is valued at $22.75 as of 16 May 2026.
What is the market capitalisation of Pacira Pharmaceuticals, Inc. PCRX?
As of 16 May 2026 Pacira Pharmaceuticals, Inc. has a market cap of $890.84M.
What is the P/E ratio of PCRX?
The Price to Earnings ratio of PCRX is 188.35.
What is the Earnings Per Share of PCRX?
The Earnings Per Share of PCRX is $0.12.
What is the 52-week high for Pacira Pharmaceuticals, Inc. stock?
The Pacira Pharmaceuticals, Inc. 52-week high stock price is $27.64.
What is the 52-week low for Pacira Pharmaceuticals, Inc. stock?
The Pacira Pharmaceuticals, Inc. 52-week low stock price is $18.80.
Can I buy PCRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PCRX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PCRX on Stake
- Buy PCRX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PCRX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PCRX related stocks